New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 5, 2014
06:33 EDTALXNAlexion's Soliris approved by FDA from accelerated to regular approval
Alexionís supplemental Biologics License Application providing regular approval for Soliris for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome to inhibit complement-mediated thrombotic microangiopathy has been approved by the FDA. This update reflects Alexionís fulfillment of post-marketing requirements, including the submission of confirmatory data from two additional prospective clinical trials, including one in pediatric patients with aHUS. The revised label now specifies important longer-term clinical benefit associated with chronic and sustained Soliris treatment with inclusion of results with two years of ongoing treatment in aHUS patients. The updated label also includes data on the use of Soliris treatment prior to use of supportive care with either plasma exchange or plasma in prospective clinical trials.
News For ALXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 5, 2016
09:26 EDTALXNLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information
06:02 EDTALXNAlexion resumed with an Outperform at Leerink
Subscribe for More Information
February 4, 2016
07:40 EDTALXNAlexion guidance conservative, says Oppenheimer
Subscribe for More Information
07:32 EDTALXNAlexion shares should be bought aggressively, says SunTrust
Subscribe for More Information
07:26 EDTALXNAlexion weakness a buying opportunity, says Brean Capital
Subscribe for More Information
February 3, 2016
09:19 EDTALXNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Boot Barn (BOOT), up 20.7%... Oclaro (OCLR), up 8.2%... Edwards Lifesciences (EW), up 5.8%... Natural Health (NHTC), up 5.7%... Viavi Solutions (VIAV), up 2.8%. ALSO HIGHER: Conatus (CNAT), up 18.8% after the FDA has granted Fast Track designation to the company's emricasan development program for the treatment of liver cirrhosis... Marvell Technology (MRVL), up 3.3% after Starboard Value disclosed a 6.7% activist stake in the company... Syngenta (SYT), up 2.9% after ChemChina offers to acquire the company in a transaction valued over $43B. DOWN AFTER EARNINGS: Navios Maritime Partners (NMM), down 33.5%... National-Oilwell Varco (NOV), down 7.9%... Chipotle (CMG), down 5.7%... Yahoo (YHOO), down 1.9%... Mondelez (MDLZ), down 4.4%... Illumina (ILMN), down 4.6%... Alexion Pharmaceuticals (ALXN), down 3.5%... Merck (MRK), down fractionally.
06:36 EDTALXNAlexion reports Q4 non-GAAP EPS $1.13, consensus $1.10
Subscribe for More Information
06:33 EDTALXNAlexion sees FY16 EPS $5.00-$5.20, consensus $5.53
Subscribe for More Information
February 2, 2016
14:32 EDTALXNNotable companies reporting before tomorrow's open
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use